Assessing the Effectiveness of Pharmacy-Based Adherence Interventions on Antiretroviral Adherence in Persons with HIV
- 1 April 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 25 (4), 221-228
- https://doi.org/10.1089/apc.2010.0324
Abstract
A key factor to the successful treatment of HIV is good adherence to antiretroviral therapy (ART). We developed a pharmacist-managed adherence clinic and designed a study to assess the impact of the adherence interventions by measuring the proportion of patients with 95% or greater adherence to ART before and after referral to the program. HIV providers referred patients with adherence problems to a pharmacist-managed adherence clinic. Interventions included scheduled clinic visits with the HIV Clinical Pharmacist and monthly refill reminders from pharmacy staff members over a 6-month period. Those aged 18–75, prescribed an ART regimen for a minimum of 3 months, and who filled their medications exclusively at the clinic pharmacy were eligible for study participation. The Proportion of Days Covered (PDC) served as a surrogate marker of overall adherence. A total of 34 patients were referred to the pharmacy clinic for adherence counseling, of whom 28 enrolled in the study. The proportion of participants with 95% or greater adherence to their ART regimen increased from 7% at baseline to 32% postintervention (p = 0.01). A subanalysis of the PDC revealed an overall increase from a baseline adherence mean of 60% to 81% postintervention (p < 0.0001). There was a notable trend toward an increase in the proportion of participants with an undetectable HIV-1 viral load (58–73%, baseline and postintervention, respectively, p = 0.10), but no statistically significant improvement in CD4 cell count. Clinical pharmacy interventions improved overall adherence to ART regimens in these patients with HIV.Keywords
This publication has 29 references indexed in Scilit:
- Use of a prescription‐based measure of antiretroviral therapy adherence to predict viral rebound in HIV‐infected individuals with viral suppressionHIV Medicine, 2010
- Antiretroviral Prescribing Patterns in Treatment-Naïve Patients in the United StatesAIDS Patient Care and STDs, 2010
- An Evidence-Based Review of Treatment-Related Determinants of Patients' Nonadherence to HIV MedicationsAIDS Patient Care and STDs, 2009
- Differential impact of adherence on long-term treatment response among naive HIV-infected individualsAIDS, 2008
- Forgiveness of non-adherence to HIV-1 antiretroviral therapyJournal of Antimicrobial Chemotherapy, 2008
- Editorial Commentary:Adherence to Antiretroviral Therapy: How Much Is Enough?Clinical Infectious Diseases, 2006
- Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical ManagementAIDS and Behavior, 2006
- Are untimed antiretroviral drug levels useful predictors of adherence behavior?AIDS, 2004
- Working Across Boundaries: Collaboration in Public ServicesHealth & Social Care in the Community, 2003
- Impact of Active Drug Use on Antiretroviral Therapy Adherence and Viral Suppression in HIV-infected Drug UsersJournal of General Internal Medicine, 2002